Upperton has submitted an application to the UK’s Medicines and Healthcare Products Regulatory Agency for approval of its new sterile manufacturing facility.

Upperton Pharma Solutions submits MHRA application for a new Annex 1–compliant sterile manufacturing facility, expanding clinical-scale CDMO capacity for biotech and pharma companies.

BioTechnique broadens capabilities with end‑to‑end fill‑finish, advanced lyophilization development, and integrated multi‑temperature 3PL support. YORK, PA, UNITED STATES, March 5, 2026 /EINPresswire.

NextPharma Technologies Announces that its Sterile Product Development Center in Belgium has been Successful in Formulating, Manufacturing and Labeling a Viscous, Lipid Based Formulation for Clinical ...

CMO's Nottingham site first to use EmulTech's ET4ME technology for GMP production of pharmaceuticals Newcastle and Eindhoven, 18 February, 2013: Aesica, the global contract manufacturing organisation ...

Unither is an independent pharmaceutical company specialising in the development and contract manufacture of the pharmaceutical formulations that patients ...

07 JAN 2026: Sharp Sterile Manufacturing has today announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will strengthen opportunities for highly ...

PARSIPPANY, N.J., Oct. 27, 2025 /PRNewswire/ -- Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, is making progress ...

DPT Laboratories defines newly-expanded sterile pharmaceutical manufacturing capabilities at its Center of Excellence in Lakewood, N.J. LAKEWOOD, N.J.--(BUSINESS WIRE)--DPT Laboratories, Ltd., a ...

Delhi, India--(Newsfile Corp. - August 21, 2025) - Akums Drugs & Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), proudly announces that its Sterile ...

Eramol today announced it will host a one-day conference on Sterile Manufacturing & Cold Chain Distribution at the Kia Oval, London, on Wednesday 19th November 2025. The event is free to attend and ...